{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:54:53Z","timestamp":1794272093158,"version":"4.9.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS115144"],"award-info":[{"award-number":["R01NS115144"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS095736"],"award-info":[{"award-number":["U01NS095736"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS100603"],"award-info":[{"award-number":["U01NS100603"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900475"],"award-info":[{"award-number":["31900475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["19ykpy146"],"award-info":[{"award-number":["19ykpy146"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["JCYJ20190807161601692"],"award-info":[{"award-number":["JCYJ20190807161601692"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2019QN01Y139"],"award-info":[{"award-number":["2019QN01Y139"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41588-021-00847-6","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T16:03:37Z","timestamp":1620317017000},"page":"787-793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-9542","authenticated-orcid":false,"given":"Ganqiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Locascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Corvol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8052-9320","authenticated-orcid":false,"given":"Xianjun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-0078","authenticated-orcid":false,"given":"Jodi","family":"Maple-Gr\u00f8dem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-5490","authenticated-orcid":false,"given":"Alexis","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lesage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Mangone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3658-571X","authenticated-orcid":false,"given":"Albert Y.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Schwarzschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Shoulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pille","family":"Taba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6087-6643","authenticated-orcid":false,"given":"Sulev","family":"K\u00f5ks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Cormier-Dequaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0630-2870","authenticated-orcid":false,"given":"Guido","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole-Bj\u00f8rn","family":"Tysnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-1737","authenticated-orcid":false,"given":"Peter","family":"Heutink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami S.","family":"Amr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus J.","family":"van Hilten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Kasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline H.","family":"Williams-Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Marinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"International Genetics of Parkinson Disease Progression (IGPP) Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus J.","family":"van Hilten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-9193","authenticated-orcid":false,"given":"Clemens R.","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46, 989\u2013993 (2014).","journal-title":"Nat. Genet."},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ng.3955","volume":"49","author":"D Chang","year":"2017","unstructured":"Chang, D. et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci. Nat. Genet. 49, 1511\u20131516 (2017).","journal-title":"Nat. Genet."},{"key":"847_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41588-018-0066-3","volume":"50","author":"C Wijmenga","year":"2018","unstructured":"Wijmenga, C. & Zhernakova, A. The importance of cohort studies in the post-GWAS era. Nat. Genet. 50, 322\u2013328 (2018).","journal-title":"Nat. Genet."},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000330228","volume":"1","author":"JJ Locascio","year":"2011","unstructured":"Locascio, J. J. & Atri, A. An overview of longitudinal data analysis methods for neurological research. Dement. Geriatr. Cogn. Dis. Extra 1, 330\u2013357 (2011).","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. & Bloem, B. R. The Parkinson pandemic\u2014a call to action. JAMA Neurol. 75, 9\u201310 (2018).","journal-title":"JAMA Neurol."},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ana.24781","volume":"80","author":"G Liu","year":"2016","unstructured":"Liu, G. et al. Specifically neuropathic Gaucher\u2019s mutations accelerate cognitive decline in Parkinson\u2019s. Ann. Neurol. 80, 674\u2013685 (2016).","journal-title":"Ann. Neurol."},{"key":"847_CR7","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1474-4422(17)30122-9","volume":"16","author":"G Liu","year":"2017","unstructured":"Liu, G. et al. Prediction of cognition in Parkinson\u2019s disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. Lancet Neurol. 16, 620\u2013629 (2017).","journal-title":"Lancet Neurol."},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland, D. et al. Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 13, 217\u2013231 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","volume":"69","author":"A Schrag","year":"2000","unstructured":"Schrag, A., Jahanshahi, M. & Quinn, N. What contributes to quality of life in patients with Parkinson\u2019s disease? J. Neurol. Neurosurg. Psychiatry 69, 308\u2013312 (2000).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson, P., Westman, E., Ballard, C. & Aarsland, D. Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol. 11, 697\u2013707 (2012).","journal-title":"Lancet Neurol."},{"key":"847_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20834","volume":"59","author":"JW Langston","year":"2006","unstructured":"Langston, J. W. The Parkinson\u2019s complex: parkinsonism is just the tip of the iceberg. Ann. Neurol. 59, 591\u2013596 (2006).","journal-title":"Ann. Neurol."},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","volume":"84","author":"CH Williams-Gray","year":"2013","unstructured":"Williams-Gray, C. H. et al. The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort. J. Neurol. Neurosurg. Psychiatry 84, 1258\u20131264 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.24777","volume":"80","author":"R Cilia","year":"2016","unstructured":"Cilia, R. et al. Survival and dementia in GBA-associated Parkinson\u2019s disease: the mutation matters. Ann. Neurol. 80, 662\u2013673 (2016).","journal-title":"Ann. Neurol."},{"key":"847_CR15","first-page":"9497147","volume":"2018","author":"S Pang","year":"2018","unstructured":"Pang, S., Li, J., Zhang, Y. & Chen, J. Meta-analysis of the relationship between the APOE gene and the onset of Parkinson\u2019s disease dementia. Parkinsons Dis. 2018, 9497147 (2018).","journal-title":"Parkinsons Dis."},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol. 7, 583\u2013590 (2008).","journal-title":"Lancet Neurol."},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/ana.24664","volume":"79","author":"I Guella","year":"2016","unstructured":"Guella, I. et al. alpha-synuclein genetic variability: a biomarker for dementia in Parkinson disease. Ann. Neurol. 79, 991\u2013999 (2016).","journal-title":"Ann. Neurol."},{"key":"847_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.parkreldis.2014.02.021","volume":"20","author":"K Markopoulou","year":"2014","unstructured":"Markopoulou, K. et al. Does alpha-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson\u2019s disease? Parkinsonism Relat. Disord. 20, 584\u2013589 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"847_CR19","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","volume":"71","author":"IF Mata","year":"2014","unstructured":"Mata, I. F. et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol. 71, 1405\u20131412 (2014).","journal-title":"JAMA Neurol."},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamaneurol.2017.4206","volume":"75","author":"KC Paul","year":"2018","unstructured":"Paul, K. C., Schulz, J., Bronstein, J. M., Lill, C. M. & Ritz, B. R. Association of polygenic risk score with cognitive decline and motor progression in Parkinson disease. JAMA Neurol. 75, 360\u2013366 (2018).","journal-title":"JAMA Neurol."},{"key":"847_CR21","doi-asserted-by":"publisher","first-page":"211 e1","DOI":"10.1016\/j.neurobiolaging.2017.04.009","volume":"56","author":"IF Mata","year":"2017","unstructured":"Mata, I. F. et al. Large-scale exploratory genetic analysis of cognitive impairment in Parkinson\u2019s disease. Neurobiol. Aging 56, 211 e1\u2013211 e7 (2017).","journal-title":"Neurobiol. Aging"},{"key":"847_CR22","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awv202","volume":"138","author":"JJ Locascio","year":"2015","unstructured":"Locascio, J. J. et al. Association between alpha-synuclein blood transcripts and early, neuroimaging-supported Parkinson\u2019s disease. Brain 138, 2659\u20132671 (2015).","journal-title":"Brain"},{"key":"847_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.22687","volume":"71","author":"N Pankratz","year":"2012","unstructured":"Pankratz, N. et al. Meta-analysis of Parkinson\u2019s disease: identification of a novel locus, RIT2. Ann. Neurol. 71, 370\u2013384 (2012).","journal-title":"Ann. Neurol."},{"key":"847_CR24","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic, J. et al. Variable expression of Parkinson\u2019s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40, 1529\u20131534 (1990).","journal-title":"Neurology"},{"key":"847_CR25","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/mds.22690","volume":"24","author":"B Ravina","year":"2009","unstructured":"Ravina, B. et al. A longitudinal program for biomarker development in Parkinson\u2019s disease: a feasibility study. Mov. Disord. 24, 2081\u20132090 (2009).","journal-title":"Mov. Disord."},{"key":"847_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/brain\/aws318","volume":"136","author":"SE Winder-Rhodes","year":"2013","unstructured":"Winder-Rhodes, S. E. et al. Glucocerebrosidase mutations influence the natural history of Parkinson\u2019s disease in a community-based incident cohort. Brain 136, 392\u2013399 (2013).","journal-title":"Brain"},{"key":"847_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.2003.017509","volume":"75","author":"J Marinus","year":"2004","unstructured":"Marinus, J. et al. A short scale for the assessment of motor impairments and disabilities in Parkinson\u2019s disease: the SPES\/SCOPA. J. Neurol. Neurosurg. Psychiatry 75, 388\u2013395 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"847_CR28","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1007\/s00415-013-6905-3","volume":"260","author":"DP Breen","year":"2013","unstructured":"Breen, D. P., Evans, J. R., Farrell, K., Brayne, C. & Barker, R. A. Determinants of delayed diagnosis in Parkinson\u2019s disease. J. Neurol. 260, 1978\u20131981 (2013).","journal-title":"J. Neurol."},{"key":"847_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/mds.26438","volume":"30","author":"LS Rosenthal","year":"2016","unstructured":"Rosenthal, L. S. et al. The NINDS Parkinson\u2019s disease biomarkers program. Mov. Disord. 30, 915\u2013923 (2016).","journal-title":"Mov. Disord."},{"key":"847_CR30","unstructured":"Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA 313, 584\u2013593 (2015)."},{"key":"847_CR31","unstructured":"1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015)."},{"key":"847_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1086\/521987","volume":"81","author":"SR Browning","year":"2007","unstructured":"Browning, S. R. & Browning, B. L. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am. J. Hum. Genet. 81, 1084\u20131097 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"847_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/gepi.20533","volume":"34","author":"Y Li","year":"2010","unstructured":"Li, Y., Willer, C. J., Ding, J., Scheet, P. & Abecasis, G. R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816\u2013834 (2010).","journal-title":"Genet. Epidemiol."},{"key":"847_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ng2088","volume":"39","author":"J Marchini","year":"2007","unstructured":"Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906\u2013913 (2007).","journal-title":"Nat. Genet."},{"key":"847_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher, P. M. et al. 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5\u201322 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"847_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.0006-341X.2000.01016.x","volume":"56","author":"S Ripatti","year":"2000","unstructured":"Ripatti, S. & Palmgren, J. Estimation of multivariate frailty models using penalized partial likelihood. Biometrics 56, 1016\u20131022 (2000).","journal-title":"Biometrics"},{"key":"847_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"BK Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291\u2013295 (2015).","journal-title":"Nat. Genet."},{"key":"847_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ejhg.2011.39","volume":"19","author":"J Yang","year":"2011","unstructured":"Yang, J. et al. Genomic inflation factors under polygenic inheritance. Eur. J. Hum. Genet. 19, 807\u2013812 (2011).","journal-title":"Eur. J. Hum. Genet."},{"key":"847_CR39","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois, B. et al. Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov. Disord. 22, 2314\u20132324 (2007).","journal-title":"Mov. Disord."},{"key":"847_CR40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: a review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"key":"847_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cell.2010.12.029","volume":"144","author":"PS Kaeser","year":"2011","unstructured":"Kaeser, P. S. et al. RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell 144, 282\u2013295 (2011).","journal-title":"Cell"},{"key":"847_CR42","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cell.2018.01.008","volume":"172","author":"C Liu","year":"2018","unstructured":"Liu, C., Kershberg, L., Wang, J., Schneeberger, S. & Kaeser, P. S. Dopamine secretion is mediated by sparse active zone-like release sites. Cell 172, 706\u2013718 e15 (2018).","journal-title":"Cell"},{"key":"847_CR43","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ajhg.2020.04.018","volume":"106","author":"S Mechaussier","year":"2020","unstructured":"Mechaussier, S. et al. Loss of function of RIMS2 causes a syndromic congenital cone-rod synaptic disease with neurodevelopmental and pancreatic involvement. Am. J. Hum. Genet. 106, 859\u2013871 (2020).","journal-title":"J. Hum. Genet."},{"key":"847_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0896-6273(04)00146-1","volume":"42","author":"CM Powell","year":"2004","unstructured":"Powell, C. M. et al. The presynaptic active zone protein RIM1alpha is critical for normal learning and memory. Neuron 42, 143\u2013153 (2004).","journal-title":"Neuron"},{"key":"847_CR45","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"847_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nature24277","volume":"550","author":"Consortium GTEx","year":"2017","unstructured":"GTEx, Consortium et al. Genetic effects on gene expression across human tissues. Nature 550, 204\u2013213 (2017).","journal-title":"Nature"},{"key":"847_CR47","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/s41593-018-0223-0","volume":"21","author":"X Dong","year":"2018","unstructured":"Dong, X. et al. Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nat. Neurosci. 21, 1482\u20131492 (2018).","journal-title":"Nat. Neurosci."},{"key":"847_CR48","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1073\/pnas.1618213114","volume":"114","author":"HF Jiao","year":"2017","unstructured":"Jiao, H. F. et al. Transmembrane protein 108 is required for glutamatergic transmission in dentate gyrus. Proc. Natl Acad. Sci. USA. 114, 1177\u20131182 (2017).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"847_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/brain\/awt338","volume":"137","author":"M Mallaret","year":"2014","unstructured":"Mallaret, M. et al. The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation. Brain 137, 411\u2013419 (2014).","journal-title":"Brain"},{"key":"847_CR50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"847_CR51","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219\u20131224 (2018).","journal-title":"Nat. Genet."},{"key":"847_CR52","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1474-4422(15)00178-7","volume":"14","author":"MA Nalls","year":"2015","unstructured":"Nalls, M. A. et al. Diagnosis of Parkinson\u2019s disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol. 14, 1002\u20131009 (2015).","journal-title":"Lancet Neurol."},{"key":"847_CR53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11481-009-9176-0","volume":"4","author":"JK Lee","year":"2009","unstructured":"Lee, J. K., Tran, T. & Tansey, M. G. Neuroinflammation in Parkinson\u2019s disease. J. Neuroimmune Pharmacol. 4, 419\u2013429 (2009).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"847_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson, M. E., Stecher, B., Labrie, V., Brundin, L. & Brundin, P. Triggers, facilitators, and aggravators: redefining Parkinson\u2019s disease pathogenesis. Trends Neurosci. 42, 4\u201313 (2019).","journal-title":"Trends Neurosci."},{"key":"847_CR55","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin, D. J. et al. Neuropathologic substrates of Parkinson disease dementia. Ann. Neurol. 72, 587\u2013598 (2012).","journal-title":"Ann. Neurol."},{"key":"847_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin, D. J. et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol. 16, 55\u201365 (2017).","journal-title":"Lancet Neurol."},{"key":"847_CR57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","volume":"17","author":"R Guerreiro","year":"2018","unstructured":"Guerreiro, R. et al. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol. 17, 64\u201374 (2018).","journal-title":"Lancet Neurol."},{"key":"847_CR58","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397 (2013).","journal-title":"Stat. Med."},{"key":"847_CR59","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/jnnp.2008.168211","volume":"80","author":"G Alves","year":"2009","unstructured":"Alves, G. et al. Incidence of Parkinson\u2019s disease in Norway: the Norwegian ParkWest study. J. Neurol. Neurosurg. Psychiatry 80, 851\u2013857 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"847_CR60","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"I Parkinson Progression Marker","year":"2011","unstructured":"Parkinson Progression Marker, I. The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"847_CR61","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1212\/01.wnl.0000266593.50534.e8","volume":"69","author":"D Verbaan","year":"2007","unstructured":"Verbaan, D. et al. Patient-reported autonomic symptoms in Parkinson disease. Neurology 69, 333\u2013341 (2007).","journal-title":"Neurology"},{"key":"847_CR62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/neup.12189","volume":"35","author":"TG Beach","year":"2015","unstructured":"Beach, T. G. et al. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program. Neuropathology 35, 354\u2013389 (2015).","journal-title":"Neuropathology"},{"key":"847_CR63","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.parkreldis.2015.05.020","volume":"21","author":"C Lucero","year":"2015","unstructured":"Lucero, C. et al. Cognitive reserve and \u03b2-amyloid pathology in Parkinson disease. Parkinsonism Relat. Disord. 21, 899\u2013904 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"847_CR64","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","volume":"91","author":"JC Corvol","year":"2018","unstructured":"Corvol, J. C. et al. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 91, e189\u2013e201 (2018).","journal-title":"Neurology"},{"key":"847_CR65","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group. DATATOP: a multicenter controlled clinical trial in early Parkinson\u2019s disease. Arch. Neurol. 46, 1052\u20131060 (1989).","DOI":"10.1001\/archneur.1989.00520460028009"},{"key":"847_CR66","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray, C. H. et al. The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132, 2958\u20132969 (2009).","journal-title":"Brain"},{"key":"847_CR67","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","volume":"125","author":"AJ Hughes","year":"2002","unstructured":"Hughes, A. J., Daniel, S. E., Ben-Shlomo, Y. & Lees, A. J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125, 861\u2013870 (2002).","journal-title":"Brain"},{"key":"847_CR68","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz, C. G. et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov. Disord. 19, 1020\u20131028 (2004).","journal-title":"Mov. Disord."},{"key":"847_CR69","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops, S. et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73, 1738\u20131745 (2009).","journal-title":"Neurology"},{"key":"847_CR70","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/mds.26062","volume":"29","author":"I van Steenoven","year":"2014","unstructured":"van Steenoven, I. et al. Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson\u2019s disease. Mov. Disord. 29, 1809\u20131815 (2014).","journal-title":"Mov. Disord."},{"key":"847_CR71","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1212\/WNL.0b013e3181bf992f","volume":"73","author":"EY Uc","year":"2009","unstructured":"Uc, E. Y. et al. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 73, 1469\u20131477 (2009).","journal-title":"Neurology"},{"key":"847_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.27492","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer, B. et al. Baseline predictors for progression 4 years after Parkinson\u2019s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa). Mov. Disord. 34, 67\u201377 (2019).","journal-title":"Mov. Disord."},{"key":"847_CR73","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/ije\/dys202","volume":"42","author":"M Kasten","year":"2013","unstructured":"Kasten, M. et al. Cohort Profile: a population-based cohort to study non-motor symptoms in parkinsonism (EPIPARK). Int. J. Epidemiol. 42, 128\u2013128k (2013).","journal-title":"Int. J. Epidemiol."},{"key":"847_CR74","doi-asserted-by":"publisher","first-page":"e0167758","DOI":"10.1371\/journal.pone.0167758","volume":"11","author":"SA Bien","year":"2016","unstructured":"Bien, S. A. et al. Strategies for enriching variant coverage in candidate disease loci on a multiethnic genotyping array. PLoS ONE 11, e0167758 (2016).","journal-title":"PLoS ONE"},{"key":"847_CR75","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"847_CR76","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/nprot.2010.116","volume":"5","author":"CA Anderson","year":"2010","unstructured":"Anderson, C. A. et al. Data quality control in genetic case-control association studies. Nat. Protoc. 5, 1564\u20131573 (2010).","journal-title":"Nat. Protoc."},{"key":"847_CR77","doi-asserted-by":"crossref","unstructured":"1000 Genomes Project Consortium et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061\u20131073 (2010).","DOI":"10.1038\/nature09534"},{"key":"847_CR78","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng1847","volume":"38","author":"AL Price","year":"2006","unstructured":"Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904\u2013909 (2006).","journal-title":"Nat. Genet."},{"key":"847_CR79","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"847_CR80","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279\u20131283 (2016).","journal-title":"Nat. Genet."},{"key":"847_CR81","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","volume":"48","author":"PR Loh","year":"2016","unstructured":"Loh, P. R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443\u20131448 (2016).","journal-title":"Nat. Genet."},{"key":"847_CR82","doi-asserted-by":"publisher","first-page":"e1002258","DOI":"10.1371\/journal.pmed.1002258","volume":"14","author":"RS Desikan","year":"2017","unstructured":"Desikan, R. S. et al. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. PLoS Med. 14, e1002258 (2017).","journal-title":"PLoS Med."},{"key":"847_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13029-015-0032-8","volume":"10","author":"G Cuellar-Partida","year":"2015","unstructured":"Cuellar-Partida, G., Renteria, M. E. & MacGregor, S. LocusTrack: integrated visualization of GWAS results and genomic annotation. Source Code Biol. Med. 10, 1 (2015).","journal-title":"Source Code Biol. Med."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00847-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T06:16:59Z","timestamp":1675232219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-021-00847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1038\/s41588-021-00847-6","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"3 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Brigham and Women\u2019s Hospital holds a US provisional patent application on the PHS for predicting PD progression, on which C.R.S. is named as inventor. Outside this work, C.R.S. has served as consultant, scientific collaborator or on scientific advisory boards for Sanofi, Berg Health, Pfizer and Biogen, and has received grants from the NIH, US Department of Defense, American Parkinson Disease Association, and the Michael J Fox Foundation (MJFF). G.L., J.J.L., J.M., A.E., J.H.G., A.Y.H., S.K., P.T., S.S.A., J.S.P. and M.C.C. report no relevant financial or other conflicts of interest in relation to this study. M.A.S. has no conflict of interest related to this work. Outside this work, M.A.S. has received grants from NINDS, DoD, MJFF, Farmer Family Foundation, and has served as a consultant to commercial programs for Eli Lilly & Co (data monitoring committee), Prevail Therapeutics (scientific advisory board), Denali Therapeutics (scientific advisory board), nQ Medical (scientific advisory board), Chase Therapeutics (scientific advisory board) and Partner Therapeutics (scientific advisory board). A.-M.W. has received research funding from the ALS Association, the Parkinson\u2019s Foundation, has participated in clinical trials funded by Acorda, Biogen, Bristol-Myers Squibb, Sanofi\/Genzyme, Pfizer and Abbvie, and received consultant payments from Mitsubishi Tanabe and from Accordant. T.M.H. has no conflict of interest related to this work. Outside this work, he has received honoraria for consulting in advisory boards for Boston Scientific and Medtronic. J.-C.C. has no conflict of interest related to this work. Outside this work, J.C.C. has received honoraria for consulting in advisory boards for Abbvie, Actelion, Air Liquide, Biogen, BMS, BrainEver, Clevexel, Denali, Pfizer, Theranexus and Zambon. B.R. is an employee of and holds equity in Praxis Precision Medicines and is advisor for Caraway Therapeutics and Brain Neurotherapy Bio. I.S. is Principal Investigator of a MJFF Computational Science Grant (2017\u201319). S.K. is supported by Multiple Sclerosis of Western-Australia (MSWA) and the Perron Institute. P.H. is a Scientific Advisor of Neuron23. J.J.v.H. has no conflict of interest related to this work. Outside this work, J.J.v.H. has received grants from the Alkemade-Keuls Foundation, Stichting Parkinson Fonds, Parkinson Vereniging, the Netherlands Organisation for Health Research and Development, the Netherlands Organisation for Scientific Research, Hersenstichting, AbbVie, MJFF, and research support from Hoffmann-La-Roche, Lundbeck and the Centre of Human Drug Research. B.M. has no conflict related to this work. Outside this work, B.M. has received honoraria for consultancy from Roche, Biogen, AbbVie, Servier and Amprion. B.M. is member of the executive steering committee of the Parkinson Progression Marker Initiative and Principal Investigator of the Systemic Synuclein Sampling Study of the MJFF for Parkinson\u2019s Research and has received research funding from the Deutsche Forschungsgemeinschaft (DFG), EU (Horizon2020), Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung, Parkinson\u2019s Foundation and MJFF. R.A.B. has no conflict of interest related to this work. Outside this work, R.A.B. has received consultancy monies from LCT, FCDI, Novo Nordisk, Cellino, Sana, UC, has received royalties from Wiley and Springer Nature, grant funding from CPT, NIHR Cambridge Biomedical Research Centre (146281), the UK Medical Research Council (MRC), Wellcome Trust (203151\/Z\/16\/Z) and Rosetrees Trust (A1519 M654). C.H.W.-G. has no conflict of interest related to this work. C.H.W.-G. is supported by a RCUK UKRI Research Innovation Fellowship awarded by the MRC (MR\/R007446\/1) and the NIHR Cambridge Biomedical Research Centre, and receives grant support from MJFF, the Evelyn Trust, the Cure Parkinson\u2019s Trust, Parkinson\u2019s UK, the Rosetrees Trust and the Cambridge Centre for Parkinson-Plus. C.H.W.-G. has received honoraria from Lundbeck and consultancy payments from Modus Outcomes and Evidera. C.T. is supported by EU Grant Horizon 2020\/propag-ageing and the MJFF. C.K. serves as a medical advisor to Centogene for genetic testing reports in the fields of movement disorders and dementia, excluding Parkinson\u2019s disease.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}